Title

Lenalidomide consolidation benefits patients with CLL receiving chemoimmunotherapy: results for CALGB 10404 (Alliance).

Document Type

Journal Article

Publication Date

7-24-2018

Journal

Blood Advances

Volume

2

Issue

14

Inclusive Pages

1705-1718

DOI

10.1182/bloodadvances.2017015396

Keywords

Adult; Aged; Aged, 80 and over; Consolidation Chemotherapy; Disease-Free Survival; Female; Humans; Immunotherapy; Lenalidomide; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Survival Rate

Peer Reviewed

1

This document is currently not available here.

Share

COinS